Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN/APP axis as novel therapeutic strategies

Hepatocellular carcinoma (HCC) poses significant treatment challenges due to high postoperative recurrence rates and the limited effectiveness of targeted medications. Researchers have identified the unique metabolic profiles of cancer stem cells (CSCs) as the primary drivers of cancer recurrence, m...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang-Yun Chen, Dao-Sian Wu, Yao-An Shen
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227524001652
Tags: Add Tag
No Tags, Be the first to tag this record!